Loading ...Health Officials Concerned Over Possible RSV Vaccine Link To Rare Neurological Condition
“Trust the science,” they told us…
At a time when the largest mRNA Covid vaccine peer-reviewed study recently revealed increases in neurological, blood, and heart-related conditions, along with the pharma-industrial complex unleashing a ‘blitzkrieg’ of vaccine commercials across corporate media outlets, a new report has found that vaccines for respiratory syncytial virus could be causing a rare nervous system disorder in older adults.
The New York Times has reported that new safety data for two RSV vaccines, presented at a meeting of scientific advisers to the Centers for Disease Control and Prevention on Thursday, indicates that Guillain-Barre syndrome – a rare condition where the immune system attacks nerve cells, leading to muscle weakness and paralysis – may have occurred in adults over 60 who received the vaccines. Two vaccines, Pfizer’s Abrysvo and GSK’s Arexvy, are currently available on the market.